Certified translation of clinical trial documentation, FDA and EMA regulatory submissions, patient medical records, IFU and drug labeling, and informed consent forms
We help businesses and individuals by offering online medical translation services provided by native speakers, certified professionals holding medical degrees.
Home > Services > Translation Services > Medical Translation >
Medical translation is a discipline that demands equal mastery of language and clinical knowledge. A translator fluent in Japanese who has never studied pharmacology cannot accurately translate a drug interaction section of an investigator's brochure. A translator fluent in German who has no clinical trial experience cannot navigate the ICH E3 structural requirements of a clinical study report. The consequences can be catastrophic. Discover our Medical & Healthcare Documents Certified Translation Use Case, and explore how certified translation services ensure accuracy and compliance in the Medical, Healthcare, and Pharmaceutical Industries.
The consequences of medical translation errors are not editorial — they are clinical, regulatory, and potentially life-threatening:
Patient safety: A mistranslated dosing instruction, a wrong drug name rendered into a target language, or an incorrect contraindication in a patient information leaflet can directly harm patients who rely on the translated document for their treatment decisions.
Regulatory rejection: An FDA or EMA submission containing translation errors in clinical data or drug labeling will be rejected or queried, delaying market authorization by months and costing millions in regulatory timeline extension.
GCP compliance failure: An informed consent form (ICF) that is translated inaccurately may not meet ICH E6(R2) Good Clinical Practice requirements — the international standard governing clinical trial conduct — potentially invalidating data from a clinical site.
Legal liability: A medical device with mistranslated Instructions for Use (IFU) may create product liability exposure for the manufacturer under the EU Medical Device Regulation if a device is used incorrectly due to the translation error.
TheWordPoint assigns every medical translation project to a translator who holds medical, pharmaceutical, or life science credentials in addition to professional translation certification. This is not a premium add-on, but the standard.
Medical and healthcare documentation leaves no room for error — which is why selecting a translation service company with verified medical expertise matters. TheWordPoint's healthcare translation services are delivered by certified translators with clinical domain knowledge in all major language pairs, including translations to Spanish for US and Latin American healthcare markets. Our medical translation practice covers the full spectrum of clinical, regulatory, pharmaceutical, and patient-facing documentation — with HIPAA compliance, ICH GCP standards, and FDA and EMA regulatory requirements applied as standard.
Patient medical records and clinical documentation. Patient histories, discharge summaries, diagnostic reports, laboratory results, radiology reports, surgical notes, pathology reports, and medical imaging findings. HIPAA-compliant with BAA available for US healthcare institutions.
Clinical trial documentation. Clinical protocols, informed consent forms (ICF), investigator brochures (IB), clinical study reports (CSR), case report forms (CRF), data safety monitoring board (DSMB) reports, and IRB/IEC submission packages. ICH GCP E6(R2) standards applied.
FDA and EMA regulatory submissions. NDA, ANDA, BLA, and 510(k) documentation. CTD dossiers. Summary of Product Characteristics (SmPC), package leaflets, and labeling for EMA market authorization. Risk Management Plans (RMP) for EMA post-marketing pharmacovigilance.
Drug labeling and pharmaceutical packaging. Prescribing information (PI), patient package inserts (PPI), medication guides, and secondary packaging text. Requires accurate rendering of INN drug names, black box warnings, and structured product labeling (SPL) format elements.
Medical device Instructions for Use (IFU) and labeling IFU translation for CE marking under EU MDR 2017/745 in all 24 EU official languages. Technical documentation and clinical evaluation reports for notified body review. → Technical Manuals Translation
Patient information and hospital materials. Patient Information Leaflets (PILs), hospital admission and discharge instructions, patient education materials, procedure consent forms, and healthcare system navigation materials for Limited English Proficiency (LEP) patient populations.
Healthcare insurance documentation. Explanation of Benefits (EOB), prior authorization documentation, health insurance policy documents, and appeals correspondence.
SOPs and GMP manufacturing documentation. Good Manufacturing Practice (GMP) standard operating procedures, validation protocols, batch manufacturing records, and regulatory inspection preparation documentation.
Medical research and scientific publications. Journal articles, research abstracts, conference presentations, systematic reviews, and grant applications for international medical research dissemination.
"Medical expertise" is a claim made by many translation services. TheWordPoint is specific about what this means:
|
Document |
Human Translation |
Machine Translation Post Editing |
|
Medical Records, Patient Histories, Diagnoses, Prescriptions |
$0.12 |
$0.08 |
|
Patient Consent Forms, Clinical Trial Documents, Medical Test Results |
$0.12 |
$0.08 |
|
Hospital Admission & Discharge Instructions, Patient Information Leaflets (PILs) |
$0.11 |
$0.07 |
|
Medical Device Manuals & Instructions |
$0.10 |
$0.07 |
| Insurance Claims & Medical Billing Statements | $0.10 | $0.07 |
| Healthcare Guidelines & Policies | $0.11 | $0.08 |
| Pharmaceutical Labels & Packaging | $0.10 | $0.07 |
Beyond institutional and pharmaceutical translation, individuals frequently need personal medical documents translated:
For US healthcare use: Foreign medical records — hospital discharge summaries from abroad, specialist consultation notes, diagnostic imaging reports from overseas facilities — translated for US treating physicians and specialists.
For USCIS immigration medical examinations: Foreign medical records and immunization histories required when applying for US permanent residence. USCIS immigration medical exams (Form I-693) are completed by USCIS-designated civil surgeons who may require access to foreign medical history. Certified translations meeting 8 CFR 103.2(b)(3) requirements are available. → Immunization Card Translation
For international healthcare: US medical records and discharge summaries translated for patients receiving follow-up care in a foreign country, or foreign nationals seeking specialist care in the United States.
To verify that you've chosen the right medical translation company, it's important to understand the types of entities that trust our services. Seeing the variety of firms we assist can help ease any doubts. We collaborate closely with biotech companies seeking to expand their global presence. Additionally, we handle pharmaceutical translations for numerous companies manufacturing products in this critical sector.
Another key client base includes medical device manufacturers, who rely on us for translating protocols and informational pamphlets into different target languages. Clinical research organizations also turn to us for assistance with translating medical journal articles and other research materials. These partnerships reflect the breadth of our expertise and commitment to delivering accurate, reliable translations to the medical sector.
No one wants to reveal the details of their interactions with a professional agency, especially when private or sensitive matters are involved. Customers often worry about the security of their documents. However, with our secure document translation service, there's no need for concern. Our strong track record speaks volumes about our commitment to confidentiality. As an accredited member of the ATA, we ensure your documents are handled with the utmost care and professionalism. Your trust in us is built on a foundation of proven reliability and security.
Clinical trial documentation translation is the most specialized and highest-value category in medical translation. A Phase III global clinical trial operating across 20 countries may require translation of the complete trial documentation set into 15–20 languages simultaneously, under strict regulatory timelines.
Core clinical trial documents requiring translation:
Informed Consent Form (ICF) — required in the subject's native language under ICH GCP E6(R2) Section 4.8.10. Must be translated at a reading comprehension level appropriate for the trial population, not in technical clinical language. Ethics committees (IRBs/IECs) in each country review and approve the local ICF translation before any subject can be enrolled at that site.
Investigator's Brochure (IB) — the background document on the investigational medicinal product, compiled for investigators. Translated for country-specific ethics committee submissions and investigator training.
Clinical Study Protocol and amendments — the governing document for trial conduct. Requires accurate translation of inclusion/exclusion criteria, dosing regimens, safety monitoring requirements, and statistical analysis specifications.
Clinical Study Report (CSR) — the comprehensive document summarizing the full trial according to ICH E3 structure. CSRs may run to thousands of pages, including statistical outputs, adverse event listings, and individual patient data narratives.
Patient-Reported Outcomes (PROs) and questionnaires — quality-of-life instruments and symptom assessments must be translated and linguistically validated (LV) according to ISPOR and ISOQOL guidelines, not just translated.
FDA (US Food and Drug Administration). Pharmaceutical companies seeking US market authorization submit New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA), or Biologics License Applications (BLA) to the FDA. For products originally developed outside the US, portions of these submissions require English translation — including clinical study reports, nonclinical data, and product information. Medical device manufacturers submit 510(k) premarket notifications or PMA (Premarket Approval) applications, which may require translated supporting documentation.
EMA (European Medicines Agency). The EMA coordinates market authorization for the EU. Marketing Authorization Applications (MAA) submitted to the EMA via the centralized procedure require translated product information (Summary of Product Characteristics, package leaflet, and labeling) in all 24 official EU languages upon approval. EMA also requires Risk Management Plan (RMP) submissions for post-marketing pharmacovigilance.
ICH GCP E6(R2) — Clinical Trials. The International Council for Harmonisation's Good Clinical Practice guideline (ICH E6(R2)) governs clinical trial conduct globally. Section 4.8.10 requires that informed consent forms be presented "in a language understandable to the subject" — making ICF translation a GCP compliance requirement, not a best practice. ICH CTD (Common Technical Document) provides the standardized structure for regulatory submissions to FDA, EMA, PMDA (Japan), and other ICH member agencies.
EU MDR 2017/745 — Medical Devices. Under the EU Medical Device Regulation, Instructions for Use (IFU) must be in all official languages of EU member states where the device is marketed. This applies to both standalone devices and software as a medical device (SaMD). IFU translation must meet the content and format requirements specified in Annex I of the EU MDR.
HIPAA — US Healthcare Institutions. US hospitals, clinics, and health insurance companies that require translation of patient health information are "Covered Entities" under HIPAA. Translation service providers handling Protected Health Information (PHI) on their behalf are "Business Associates" and must execute a Business Associate Agreement (BAA). TheWordPoint provides BAAs for US healthcare institution clients.
Title VI — Limited English Proficiency (LEP) in US Healthcare. Under Title VI of the Civil Rights Act of 1964, as interpreted by the Department of Health and Human Services, healthcare providers receiving federal funds (Medicare, Medicaid) must provide meaningful access to patients with limited English proficiency — including translated patient-facing materials. This creates a specific, ongoing demand for patient-language medical translation in US hospital systems.
Prices differ depending on the topic of the text, material complexity, language pairs, and the turnaround. TheWordPoint price for medical text translation starts from $0.08 per word, please contact our Account Manager for an accurate price quote.
Not as primary translation. Human medical-credentialed translators only for all primary projects. MTPE available as a separate service for lower-exposure content where clients have existing MT output for review.
Yes — including immunization records and foreign medical history for USCIS immigration medical examinations, certified per 8 CFR 103.2(b)(3).
$0.08–$0.12/word for human translation depending on document type. MT post-editing at $0.07–$0.08/word for applicable content. Language pair affects rate — Japanese, Chinese, Korean, Arabic cost more than European pairs.
It means executing a Business Associate Agreement (BAA) with the covered entity before handling any Protected Health Information (PHI), and applying HIPAA Security Rule safeguards to all electronic PHI. TheWordPoint provides BAAs for US healthcare institutional clients.
ICH E6(R2) Section 4.8.10 requires that informed consent forms be in a language the subject understands — making ICF translation a GCP compliance requirement. ICH CTD governs the structure of regulatory submissions to FDA, EMA, and PMDA.
Yes. NDA, ANDA, BLA, and 510(k) documentation, with translators holding pharmaceutical or clinical research credentials relevant to the submission type.
MD, MBBS, PharmD, BPharm, life science PhD, RN, CRA/CRC, or biomedical engineering credentials — verified before every project assignment, matched by specialty.
Yes. EU MDR 2017/745 requires IFU in all EU official languages where the device is marketed. Non-compliance is a CE marking violation.
Yes. EU health data processed under GDPR Article 9 with appropriate legal basis and data processing agreement.
Yes. Marketing Authorization Applications (MAA), Summary of Product Characteristics (SmPC), package leaflets, and Risk Management Plans.
Can’t find an answer to your questions? Feel free to check our complete FAQ page, or contact us at [email protected]
Our Support is available round the clock to make sure that the working process is smooth and comfortable.
Your personal account was created successfully. Login details were sent to your email.
Thank you for choosing our service!
You have registered your account successfully!
Your application was sent to our
HR Departament.
Get prepared to pass several proficiency tests to prove your skills as we hire only the best experts to deliver the best quality to our Clients. We will contact you soon for futher instructions